Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus

Cog-ID Study Grp, Onno N. Groeneveld*, Esther van den Berg, Guy E. H. M. Rutten, Paula S. Koekkoek, L. Jaap Kappelle, Geert Jan Biessels

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)


Aims: Type 2 diabetes mellitus (T2DM) is associated with subtle cognitive changes, but also with more severe stages of cognitive dysfunction, including mild cognitive impairment (MCI) and dementia. For these severe stages, it is uncertain which domains are primarily affected and if all patients with impairment are captured by formal criteria for MCI or dementia.

Methods: Ninety-five patients with T2DM suspected of cognitive impairment, identified through screening in primary care, underwent neuropsychological examination assessing five different domains. MCI or dementia were diagnosed using formal criteria.

Results: Forty-seven participants (49%) had impairment on at least one domain, most often involving memory (30%), information processing speed (22%) and visuoperception and construction (22%). Of these 47 people, 29 (62%) had multi-domain impairment. Of the 47 participants with objective impairment, 36 (77%) met criteria for MCI, three (6%) for dementia and eight (17%) met neither diagnosis, mostly because these patients did not complain about acquired dysfunction.

Conclusions: This study shows that the clinical diagnostic evaluation of cognitive impairment in patients with T2DM should take into account that multiple domains can be affected and that not all patients with objective cognitive impairment fulfill criteria for MCI or dementia. (C) 2018 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)92-99
Number of pages8
JournalDiabetes Research & Clinical Practice
Publication statusPublished - Aug 2018

Research programs

  • EMC OR-01


Dive into the research topics of 'Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this